Moderna Inc
USUSDModerna Inc (US:MRNA) — Biotechnology: Biological Products (No Diagnostic Substances). Börside arv, kus ettevõtte aktsiatega kaubeldakse: 2. Sellel lehel — hind ja graafik, dividendid, suurimad aktsionärid ja aktsiate arvu ajalugu.
Ettevõtte kohta
- Veebileht
- modernatx.com
- Sektor
- Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
- Peakontor
- Cambridge, United States
- Tegevjuht
- Stéphane Bancel
- Töötajad
- 5 800
- Asutatud
- 2010
- Ringluses olevad aktsiad
- 399.24 mln seisuga 2026-07-24
- Vabalt kaubeldavad aktsiad
- 372.19 mln
- Turukapitalisatsioon
- 76.88 mld USD
- Siseringi isikud
- 7.34%
- Institutsionaalsed investorid
- 80.46%
- Tegevusala (SIC)
- Biological Products, (No Diagnostic Substances)
- ISIN
- US60770K1079
- LEI
- 549300EI6OKH5K5Q2G38
Kirjeldus
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Dividendid
Dividendimakseid ei leitud (kontrollitud 06.10.2026). Ettevõte ilmselt dividende ei maksa.
News this week
Ettevõtte veebisaidilt uudiseid veel pole.
Suurimad omanikud
| Omanik | Osalus | Aktsiad | Aruande kuupäev |
|---|---|---|---|
| FMR, LLC | 12.99% | 51.86 mln | 2026-06-30 |
| Blackrock Inc. | 7.66% | 30.6 mln | 2026-06-30 |
| Vanguard Capital Managem… | 5.81% | 23.21 mln | 2026-06-30 |
| Capital World Investors | 5.58% | 22.28 mln | 2026-06-30 |
| Stéphane Bancel (Chief E… | ≈5.56% | 22.22 mln | 2026-08-06 |
| BAILLIE GIFFORD & CO | 4.56% | 18.21 mln | 2026-06-30 |
| State Street Corporation | 3.94% | 15.73 mln | 2026-06-30 |
| Vanguard Portfolio Manag… | 3.9% | 15.58 mln | 2026-06-30 |
| Growth Fund of America | 3.75% | 14.98 mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.84% | 11.33 mln | 2026-06-30 |
| Geode Capital Management… | 2.43% | 9.71 mln | 2026-06-30 |
| Morgan Stanley | 2.39% | 9.54 mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.29% | 9.15 mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.05% | 8.19 mln | 2026-06-30 |
| Theleme Partners LLP | 2.02% | 8.06 mln | 2026-06-30 |
| Fidelity Mt. Vernon Stre… | 1.7% | 6.79 mln | 2026-07-31 |
| Fidelity Securities Fund… | 1.33% | 5.31 mln | 2026-07-31 |
| VANGUARD INDEX FUNDS-Van… | 1.3% | 5.19 mln | 2026-06-30 |
| iShares Trust-iShares Co… | 1.18% | 4.7 mln | 2026-08-31 |
| AMERICAN FUNDS INSURANCE… | 1.16% | 4.62 mln | 2026-06-30 |
| VANGUARD WORLD FUND-Vang… | 1.15% | 4.58 mln | 2026-05-31 |
| HOGE STEPHEN (President) | ≈0.43% | 1.72 mln | 2026-09-15 |
| KLINGER SHANNON THYME (O… | ≈0.02% | 81 340 | 2026-09-04 |
| MOCK JAMES M (Chief Fina… | ≈0.01% | 59 375 | 2026-09-10 |
| NADER FRANCOIS E. (Direc… | ≈0.01% | 32 781 | 2026-04-30 |
| NABEL ELIZABETH G (Direc… | ≈0% | 19 317 | 2026-04-30 |
| HORNING SANDRA (Director… | ≈0% | 18 585 | 2026-04-30 |
| HUSSAIN SHAH ABBAS (Dire… | ≈0% | 12 066 | 2026-05-01 |
| Robert S. Langer, Jr. | — | — | — |
| Noubar Afeyan (Director) | — | — | 2026-05-21 |
| SAGAN PAUL L (Director) | — | — | 2025-03-03 |
Järelevalveasutuse sündmused
| Kuupäev | Järelevalveasutus | Sündmus | Üksikasjad |
|---|---|---|---|
| 2026-10-02 | ESMA | оновлення даних інструмента | ISIN, майданчик HAND |
| 2026-09-30 | SEC | поточний звіт | Форма 8-K |
